Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
25.00
+0.26 (1.05%)
At close: May 29, 2026, 4:00 PM EDT
24.85
-0.15 (-0.60%)
After-hours: May 29, 2026, 6:34 PM EDT
Pulse Biosciences Revenue
Pulse Biosciences had revenue of $401.00K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $751.00K. In the year 2025, Pulse Biosciences had annual revenue of $350.00K.
Revenue (ttm)
$751.00K
Revenue Growth
n/a
P/S Ratio
2,303.92
Revenue / Employee
$6,474
Employees
116
Market Cap
1.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 350.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 700.00K | -718.00K | -50.63% |
| Dec 31, 2021 | 1.42M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.68B |
| MiniMed Group | 2.99B |
| Warby Parker | 890.57M |
| Azenta | 596.48M |
| AtriCure | 552.16M |
| STAAR Surgical Company | 290.38M |
| LeMaitre Vascular | 256.28M |
| BioLife Solutions | 101.66M |
PLSE News
- 3 days ago - Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Business Wire
- 17 days ago - Pulse Biosciences Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 18 days ago - Pulse Biosciences Slides: Corporate presentation - Filings
- 18 days ago - Pulse Biosciences announces ATM equity purchases by co-chairmen - TheFly
- 19 days ago - ATM Equity Purchases by Pulse Biosciences' Co-Chairmen Total Approximately $13.3 Million - Business Wire
- 19 days ago - Pulse Biosciences Proxy statement: Proxy filing - Filings
- 22 days ago - Pulse Biosciences Q1 Earnings Call Highlights - MarketBeat
- 23 days ago - Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference - Business Wire